Hedge Fund - Ariel Investments
Charles River Laboratories International Inc. (CRL)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $248,385,007 | 2.47% | 1,050,698 | $196.66 |
| 2 | 2023 - Q3 (2023-09-30) | $209,032,268 | 2.21% | 1,066,600 | $205.30 |
| 3 | 2023 - Q2 (2023-06-30) | $220,308,361 | 2.08% | 1,047,840 | $198.96 |
| 4 | 2023 - Q1 (2023-03-31) | $137,853,959 | 1.32% | 683,054 | $226.63 |
| 5 | 2022 - Q4 (2022-12-31) | $138,968,341 | 1.41% | 637,762 | $218.37 |
| 6 | 2022 - Q3 (2022-09-30) | $128,018,000 | 1.4% | 650,498 | $215.88 |
| 7 | 2022 - Q2 (2022-06-30) | $126,165,000 | 1.25% | 589,639 | $244.35 |
| 8 | 2022 - Q1 (2022-03-31) | $59,575,000 | 0.52% | 209,795 | $308.36 |
| 9 | 2021 - Q4 (2021-12-31) | $67,688,000 | 0.57% | 179,647 | $388.52 |
| 10 | 2021 - Q3 (2021-09-30) | $75,603,000 | 0.69% | 183,205 | $415.31 |
| 11 | 2021 - Q2 (2021-06-30) | $81,789,000 | 0.76% | 221,099 | $333.92 |
| 12 | 2021 - Q1 (2021-03-31) | $119,141,000 | 1.17% | 411,073 | $277.97 |
| 13 | 2020 - Q4 (2020-12-31) | $103,159,000 | 1.16% | 412,866 | $238.16 |
| 14 | 2020 - Q3 (2020-09-30) | $111,038,000 | 1.61% | 490,342 | $207.53 |
| 15 | 2020 - Q2 (2020-06-30) | $108,900,000 | 1.65% | 624,606 | $159.60 |
| 16 | 2020 - Q1 (2020-03-31) | $86,527,000 | 1.51% | 685,583 | $149.98 |
| 17 | 2019 - Q4 (2019-12-31) | $129,860,000 | 1.62% | 850,094 | $138.46 |
| 18 | 2019 - Q3 (2019-09-30) | $111,402,000 | 1.48% | 841,597 | $134.08 |
| 19 | 2019 - Q2 (2019-06-30) | $115,720,000 | 1.45% | 815,507 | $135.63 |
| 20 | 2019 - Q1 (2019-03-31) | $122,946,000 | 1.52% | 846,442 | $131.38 |
| 21 | 2018 - Q4 (2018-12-31) | $111,841,000 | 1.55% | 988,171 | $125.21 |
| 22 | 2018 - Q3 (2018-09-30) | $168,709,000 | 1.86% | 1,253,966 | $123.42 |
| 23 | 2018 - Q2 (2018-06-30) | $147,912,000 | 1.65% | 1,317,586 | $108.11 |
| 24 | 2018 - Q1 (2018-03-31) | $145,303,000 | 1.65% | 1,361,277 | $107.79 |
| 25 | 2017 - Q4 (2017-12-31) | $148,107,000 | 1.67% | 1,353,195 | $108.82 |
| 26 | 2017 - Q3 (2017-09-30) | $181,481,000 | 2.1% | 1,680,066 | $102.74 |
| 27 | 2017 - Q2 (2017-06-30) | $197,280,000 | 2.33% | 1,950,367 | $92.05 |
| 28 | 2017 - Q1 (2017-03-31) | $185,335,000 | 2.17% | 2,060,420 | $84.93 |
| 29 | 2016 - Q4 (2016-12-31) | $120,141,000 | 1.41% | 1,576,856 | $75.95 |
| 30 | 2016 - Q3 (2016-09-30) | $118,913,000 | 1.43% | 1,426,842 | $83.83 |
| 31 | 2016 - Q2 (2016-06-30) | $120,703,000 | 1.51% | 1,464,130 | $82.37 |
| 32 | 2016 - Q1 (2016-03-31) | $126,589,000 | 1.52% | 1,666,955 | $74.02 |
| 33 | 2015 - Q4 (2015-12-31) | $140,111,000 | 1.67% | 1,742,890 | $72.12 |
| 34 | 2015 - Q3 (2015-09-30) | $106,353,000 | 1.32% | 1,674,330 | $71.81 |
| 35 | 2015 - Q2 (2015-06-30) | $118,147,000 | 1.33% | 1,679,650 | $74.00 |
| 36 | 2015 - Q1 (2015-03-31) | $139,427,000 | 1.56% | 1,758,445 | $73.77 |
| 37 | 2014 - Q4 (2014-12-31) | $127,538,000 | 1.47% | 2,004,055 | $62.69 |
| 38 | 2014 - Q3 (2014-09-30) | $119,257,000 | 1.53% | 1,996,270 | $57.22 |
| 39 | 2014 - Q2 (2014-06-30) | $104,399,000 | 1.27% | 1,950,657 | $54.87 |
| 40 | 2014 - Q1 (2014-03-31) | $121,239,000 | 1.47% | 2,009,262 | $58.29 |
| 41 | 2013 - Q4 (2013-12-31) | $139,454,000 | 1.71% | 2,629,217 | $50.22 |
| 42 | 2013 - Q3 (2013-09-30) | $127,211,000 | 1.85% | 2,749,905 | $45.89 |
| 43 | 2013 - Q2 (2013-06-30) | $112,194,000 | 1.83% | 2,734,450 | $42.84 |
| 44 | 2013 - Q1 (2013-03-31) | $122,338,000 | 2.09% | 2,763,450 | $41.89 |
| 45 | 2012 - Q4 (2012-12-31) | $102,815,000 | 2.15% | 2,743,925 | $38.94 |
| 46 | 2012 - Q3 (2012-09-30) | $113,206,000 | 2.42% | 2,858,725 | $35.87 |
| 47 | 2012 - Q1 (2012-03-31) | $108,801,000 | 2.23% | 3,014,710 | $34.28 |
| 48 | 2011 - Q4 (2011-12-31) | $79,414,000 | 1.82% | 2,905,745 | $28.64 |
| 49 | 2011 - Q3 (2011-09-30) | $28,517,000 | 0.75% | 996,415 | $34.65 |
The displayed share prices are average quarterly stock market prices.